Form 4 holding
Director, 10%+ Owner
Arbutus Biopharma Corp
- Security class
- Common Shares
- Shares / value
- 29,880,079
- Estimated value
- $143,424,379
- Report date
- 01 Oct 2026
- Price
- $4.80
- Ownership
- Direct
Roivant Sciences Ltd. - Director, 10%+ Owner at Arbutus Biopharma Corp
Issuer-level insider activity
- Role
- Director, 10%+ Owner
- Issuer ticker
- ABUS on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Roivant Sciences Ltd. since 27 Oct 2025
Reported holdings for Roivant Sciences Ltd. in Arbutus Biopharma Corp
Form 4 holding
Director, 10%+ Owner
Arbutus Biopharma Corp
- Security class
- Common shares, without par value
- Shares / value
- 38,847,462
- Estimated value
- Report date
- 18 Oct 2021
- Price
- Ownership
- Direct
Form 4 holding
Director, 10%+ Owner
Arbutus Biopharma Corp
- Security class
- Series A participating convertible preferred shares
- Shares / value
- 0
- Estimated value
- Report date
- 18 Oct 2021
- Price
- Ownership
- Direct
- Underlying class
- Common shares
- Underlying amount
Transaction history for Roivant Sciences Ltd. in Arbutus Biopharma Corp
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.